XJPX7681
Market cap12mUSD
Dec 26, Last price
979.00JPY
1D
-3.36%
1Q
-4.95%
IPO
-28.71%
Name
Leoclan Co Ltd
Chart & Performance
P/E
7.08
P/S
0.07
EPS
138.37
Div Yield, %
5.10%
Shrs. gr., 5y
—
Rev. gr., 5y
3.65%
Revenues
26.63b
-10.53%
Net income
271m
-37.92%
CFO
342m
+40.93%
Dividend
Sep 27, 202450 JPY/sh
Profile
LEOCLAN Co.,Ltd. operates as a medical equipment trading company that meets various medical care, welfare, and health needs. It operates through three segments: Medical Total Solutions Business, Remote Image Diagnosis Service Business, and School Lunch Business. The Medical Total Solutions Business segment provides incidental maintenance services; and interior decoration construction and installation works for medical institutions, preventive/health checkup facilities, nursing care/welfare facilities, etc. based on consulting services such as selection of medical equipment, as well as sells medical equipment and medical information systems. The Remote Image Diagnosis Service Business segment offers services in which diagnostic radiology specialists remotely diagnose image data taken by MRI, CT, etc., and provides information. The School Lunch Business segment provides school lunch services, including regular meals, medical meals, and other meals to nursing care and welfare facilities. LEOCLAN Co.,Ltd. was incorporated in 2001 and is headquartered in Settsu, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | |
| Income | |||||
Revenues | 26,632,145 -10.53% | 29,767,431 12.98% | |||
Cost of revenue | 23,813,730 | 26,711,652 | |||
Unusual Expense (Income) | |||||
NOPBT | 2,818,415 | 3,055,779 | |||
NOPBT Margin | 10.58% | 10.27% | |||
Operating Taxes | 145,899 | 219,125 | |||
Tax Rate | 5.18% | 7.17% | |||
NOPAT | 2,672,516 | 2,836,654 | |||
Net income | 271,307 -37.92% | 437,051 11.78% | |||
Dividends | (97,962) | (78,421) | |||
Dividend yield | 5.40% | 5.18% | |||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | 92,500 | ||||
Long-term debt | 2,017 | 5,672 | |||
Deferred revenue | (54,738) | ||||
Other long-term liabilities | 879,000 | 912,251 | |||
Net debt | (5,776,420) | (5,610,631) | |||
| Cash flow | |||||
Cash from operating activities | 341,555 | 242,357 | |||
CAPEX | (51,000) | (46,890) | |||
Cash from investing activities | (82,011) | (49,958) | |||
Cash from financing activities | (202,311) | (120,931) | |||
FCF | 2,687,850 | 2,867,883 | |||
| Balance | |||||
Cash | 5,537,421 | 5,480,189 | |||
Long term investments | 241,016 | 228,614 | |||
Excess cash | 4,446,830 | 4,220,431 | |||
Stockholders' equity | 5,112,826 | 5,039,299 | |||
Invested Capital | 2,154,987 | 2,114,433 | |||
ROIC | 125.19% | 157.33% | |||
ROCE | 42.69% | 47.85% | |||
| EV | |||||
Common stock shares outstanding | 1,973 | 1,973 | |||
Price | 919.67 19.96% | 766.67 -28.35% | |||
Market cap | 1,814,363 19.95% | 1,512,606 -28.29% | |||
EV | (3,804,450) | (3,944,674) | |||
EBITDA | 2,922,843 | 3,152,058 | |||
EV/EBITDA | |||||
Interest | 840 | 1,116 | |||
Interest/NOPBT | 0.03% | 0.04% | |||